Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis: Commentary

Tom Huizinga^*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	146-147
Number of pages	2
Journal	International Journal of Advances in Rheumatology
Volume	8
Issue number	4
State	Published - Dec 1 2010

ASJC Scopus subject areas

@article{422814235ecb4bdc8b606643935978e9,

title = "Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis: Commentary",

author = "Tom Huizinga and Peter Nigrovic and Eric Ruderman and Hendrik Schulze-Koops",

year = "2010",

month = dec,

day = "1",

language = "English (US)",

volume = "8",

pages = "146--147",

journal = "International Journal of Advances in Rheumatology",

issn = "1478-856X",

publisher = "Remedica Medical Education and Publishing Ltd",

number = "4",

}

TY - JOUR

T1 - Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis

T2 - Commentary

AU - Huizinga, Tom

AU - Nigrovic, Peter

AU - Ruderman, Eric

AU - Schulze-Koops, Hendrik

PY - 2010/12/1

Y1 - 2010/12/1

UR - http://www.scopus.com/inward/record.url?scp=84863872663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863872663&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:84863872663

SN - 1478-856X

VL - 8

SP - 146

EP - 147

JO - International Journal of Advances in Rheumatology

JF - International Journal of Advances in Rheumatology

IS - 4

ER -